Precision Tumor Detection for Personalized Medicine

Precision Tumor Detection is designed for patients with Colorectal Cancer (CRC) , Non-Small Cell Lung Cancer (NSCLC) and other solid tumors to detect unique gene mutations and then provide personalized therapy guidelines of targeted drugs.

Features:

Precision Tumor Detection utilizes market leading tissue-based capture approach that provide actionable benefits for cancer patients and oncologists. It covers 198 cancer-related genes, accurately identifying biomarkers like SNV, InDel, Fusion, CNV and MSI, and guides the selection of 42 recommended therapeutic drugs, including those recommended in the latest NCCN guidelines.
Technical Advantages for Precision Tumor Detection
Product Lines of Precision Tumor Detection
Sample Detection Process